4basebio (4BB) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. 4basebio

NOTE: This is based on 3 open tips for 4basebio (4BB)


4basebio (4BB)
Latest Quote Price

525.00p

4basebio (4BB)
Price Change (%)

-0.95%


Latest Bid : 500.00p Latest Ask : 550.00p
High Today : 525.00p Low Today : 501.00p
This Years High : 1,000.00p This Years Low : 440.83p
Volume : 474 MKT Cap : £78.75M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

4basebio (4BB) Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

4basebio (4BB) Latest Tips

Type Tipster SectorScore Start date Performance
Outperform RBC Capital Premium Only 2026-06-15 18:00:00 15/06/2026 0.00%
Outperform RBC Capital Premium Only 2025-10-02 10:51:00 02/10/2025 -34.38%
Outperform RBC Capital Premium Only 2025-03-13 18:00:00 13/03/2025 -53.13%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


4basebio (4BB) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 500.00p Latest Ask : 550.00p
High Today : 525.00p Low Today : 501.00p
This Years High : 1,000.00p This Years Low : 440.83p
Volume : 474 MKT Cap : £78.75M

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest 4basebio Tips

Type Tipster SectorScore Start date Performance
Outperform RBC Capital Premium Only 2026-06-15 18:00:00 15/06/2026 0.00%
Outperform RBC Capital Premium Only 2025-10-02 10:51:00 02/10/2025 -34.38%
Outperform RBC Capital Premium Only 2025-03-13 18:00:00 13/03/2025 -53.13%